BackBrickell Biotech Overview

Brickell Biotech Total Liabilities

Brickell Biotech's total liabilities is $2.9M.

Get informed when a big investor buys or sells

+ Follow
Total Liabilities
$2.87M
↓ 57.29% YoYΔ $-3.85M vs prior year quarter

Peer trimmed avg / median

Loading

Brickell Biotech Total Liabilities History

Loading

Brickell Biotech vs. peers: Total Liabilities Comparison

Loading

Brickell Biotech Total Liabilities Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Brickell Biotech (BBI) FAQ

As of the most recent data (June 2022), BBI shows a total liabilities of $2.9M. That compares with $6.7M in the prior-year period — down 57.3% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, BBI's total liabilities is now $2.9M (was $6.7M) — a 57.3% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether Brickell Biotech is outperforming or lagging.

Tracking BBI's total liabilities over time shows whether Brickell Biotech is scaling, shrinking, or reshaping that part of the business. The current reading is $2.9M That compares with $6.7M in the prior-year period — down 57.3% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this total liabilities page, Stockcircle has Brickell Biotech's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect total liabilities (currently $2.9M) with ownership activity and broader fundamentals.

Brickell Biotech's total liabilities is $2.9M; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.